An alternative pathway for preclinical research in fluid management

Area of Science:

• Critical care medicine
• Pharmacology
• Translational research

Background:

• Recent meta-analyses have introduced uncertainty regarding the use of colloid resuscitation fluids in critically ill patients.
• Methodological limitations in these meta-analyses may question current shifts in fluid management practices.
• There is a need for further research to clarify the impact of resuscitation fluid choice on patient outcomes.

Purpose of the Study:

• To highlight the importance of animal studies in evaluating the efficacy and safety of resuscitation fluids before clinical trials.
• To propose an alternative preclinical research pathway to mitigate failures in large-scale clinical trials, particularly for sepsis therapies.
• To ensure promising therapies are pursued by optimizing the evaluation process.

Main Methods:

• Utilizing animal studies to predict the effectiveness and safety of resuscitation fluids for clinical trials.
• Implementing a competitive request for proposals for independent investigators to test developer hypotheses in randomized animal models.
• Applying critical appraisal principles, including meta-analysis of animal data, to preclinical findings.

Main Results:

• Animal studies can reliably indicate the potential success or failure of fluids in human trials.
• A structured preclinical pathway can help avoid costly clinical trial failures.
• Rigorous evaluation of preclinical data is essential before initiating large clinical trials.

Conclusions:

• Animal research is crucial for guiding the clinical application of resuscitation fluids.
• An alternative preclinical evaluation pathway, involving hypothesis testing in animal models and critical appraisal, can improve therapeutic development.
• This approach may prevent the abandonment of potentially beneficial therapies due to premature clinical trial failures.